Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer
This tumor board will discuss how to select the most appropriate therapy for patients with lung cancer using a case-based format.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 2.2021
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.
Category
  • Lung Cancers
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Accurate Diagnosis and Personalized Treatment of NSCLC for the Interdisciplinary Team
It is essential that all members of the NSCLC care team understand the necessary processes and are equipped to apply current research on genomic targets to testing for mutations/drivers in appropriate advanced NSCLC patients.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer
Nurses and other health care providers need to be familiar with the new approved agents (and their corresponding molecular biomarkers) and side effects associated with the newer agents, so they can improve care for their patients.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Challenging Case Review: Non-Small Cell Lung Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Non-Small Cell Lung Cancer: Biomarker Testing Recommendations
The rapid pace of updates to the NCCN Guidelines for Non-Small Cell Lung Cancer makes it challenging for health care providers to stay informed about the newest recommendations. Health care providers need to be aware of the latest NCCN recommendations to improve care for their patients with metastatic NSCLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Targeted Therapies and Immunotherapies for Metastatic Non-Small Cell Lung Cancer
The rapid pace of updates to the NCCN Guidelines for Non-small Cell Lung Cancer makes it challenging for health care providers to stay informed about the newest recommendations, including side effects with these agents. Health care providers need to be aware of the latest NCCN recommendations to improve care for their patients with metastatic NSCLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Multidisciplinary Treatment of Early-Stage Non-Small Cell Lung Cancer
Before a specific multidisciplinary treatment plan is recommended for an individual patient, multidisciplinary evaluation in tumor boards is often advised to ensure the patient receives the most appropriate treatment. The multidisciplinary team approach has been shown to improve outcomes in patients with lung cancer.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
TARGET FOR NSCLC: The Advancing Research into Genomic Pathways and use of EGFR Therapies
The goal of this initiative is to increase clinicians’ knowledge and improve their competence in understanding the latest advances in targeting genomic pathways for the treatment of non-small cell lung cancer (NSCLC) through a review of the current and ongoing research/clinical trials focused on
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation